Phase III Study Comparing the Use of Docetaxel on a Every Three-Week vs. Weekly Schedule in the Treatment of Patients With Metastatic Breast Cancer.
Phase of Trial: Phase III
Latest Information Update: 27 Jul 2012
At a glance
- Drugs Docetaxel (Primary)
- Indications Advanced breast cancer
- Focus Registrational; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 01 Apr 2008 Results have been published.
- 17 Sep 2005 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History